The management choice for newly diagnosed localized prostate cancer presents a challenge to both the physician and the patient. Traditionally, surgery and radiation therapy have been the most commonly recommended options. More recently, active surveillance is recommended as the preferred management choice for a subset of men with localized, low-risk cancer. Recent reports also suggest that focal cryotherapy may be considered as a management option for selected cases of clinically localized prostate cancer.
Methods
A review of the literature on focal cryotherapy from 2002 to 2012 was performed. Outcomes on cancer control, complications, and quality of life were extracted and assessed.
Results
The biochemical disease-free survival at 5 years is comparable to whole gland treatment modalities. Complications are minimal and comparable with other local treatment modalities.
Conclusions
Focal cryotherapy is safe and effective, and it may improve failure rates in men who initially pursue active surveillance protocols. Early outcomes with cancer control are encouraging.
References
1.
Neppl-HuberC., ZappaM., CoeberghJ.W.. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths.Ann Oncol.2012; 23(5): 1325–1334.
2.
KlotzL., ZhangL., LamA.. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.J Clin Oncol.2010; 28(1): 126–131.
3.
AbernM., TsivianM., PolascikT.. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.Curr Urol Rep.2012; 13(2): 160–169.
4.
WiltT., BrawerM., JonesK.. Radical prostatectomy versus observation for localized prostate cancer.N Engl J Med.2012; 367(3): 203–213.
5.
HoffmannN.E., BischofJ.C.. The cryobiology of cryosurgical injury.Urology.2002; 60(2 suppl 1): 40–49.
BottS.R., AhmedH.U., HindleyR.G.. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer.BJU Int.2010; 106(11): 1607–1611.
8.
KaravitakisM., WinklerM., AbelP.. Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy.Prostate Cancer Prostatic Dis.2011; 14(1): 46–52.
9.
BarzellW., MelamedM.. Appropriate patient selection for focal therapy of prostate cancer: the role of transperineal 3-dimensional mapping of the prostate - an 8-year experience.Urology.2010; 183(4 suppl): e56.
10.
FalzaranoS.M., ZhouM., HernandezA.V.. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.Urology.2010; 76(3): 682–687.
11.
TurkbeyB., ManiH., ShahV.. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.J Urol.2011; 186(5): 1818–1824.
12.
RastinehadA.R., BaccalaAAJr, ChungP.H.. D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.J Urol.2011; 185(3): 815–820.
13.
PintoP.A., ChungP.H., RastinehadA.R.. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.J Urol.2011; 186(4): 1281–1285.
14.
SimmonsL.A., AutierP., Zát'uraF.. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning™.BJU Int.2012; 110(1): 28–35.
15.
WalzJ., MarcyM., PiannaJ.T.. Identification of the prostate cancer index lesion by real-time elastography: considerations for focal therapy of prostate cancer.World J Urol.2011; 29(5): 589–594.
16.
OnikG., NarayanP., VaughanD.. Focal “nerve-sparing” cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency.Urology.2002; 60(1): 109–114.
17.
OnikG., VaughanD., LotenfoeR.. The “male lumpectomy”: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up.Urol Oncol.2008; 26(5): 500–505
18.
WardJ.F., JonesJ.S.. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry.BJU Int.2012; 109(11): 1648–1654.
19.
BahnD., de Castro AbreuA.L., GillI.S.. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.Eur Urol.2012; 62(1): 55–63.
20.
LambertE.H., BolteK., MassonP.. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.Urology.2007; 69(6): 1117–1120.
21.
EllisD.S., MannyTBJr, RewcastleJ.C.. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.Urology.2007; 70(6 suppl): 9–15.
22.
AbernM.R., TsivianM., PolascikT.J.. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.Curr Urol Rep.2012; 13: 160–169.
23.
BabaianR.J., DonnellyB., BahnD.. Best practice statement on cryosurgery for the treatment of localized prostate cancer.J Urol.2008; 180(5): 1993–2004.
